a16z15 min
a16z Podcast | Revisiting the Gene
- Genomic applications will rest on a foundational sequencing layer characterized by rapid, reliable, and low-cost data acquisition.
- Costs for interpreting genomic data are projected to increase by 100 to 1,000 times relative to acquisition expenses.
- Computational models are planned to guide variant interpretation teams regarding molecular and cellular effects and to predict outcomes for the 9.4% of currently unknown mutations.
- Diagnostic metrics for predictive models will be prospectively tracked and audited to ensure value.
- Dynamic DNA-based applications theoretically enable disease detection associated with immune changes.
- Post-launch learning mechanisms are expected to improve accuracy over time, reducing the likelihood of errors after initial AI-based diagnostic deployment.
- A new diagnostic approach aims to capture a fraction of the 35 million unscreened individuals, potentially creating a clinical trial one to two orders of magnitude larger than previous announcements.
- Payment models will likely expand to include life insurance companies and hospital closed systems, though these methods remain in early development stages.
- The healthcare system is forecasted to undergo a permanent transformation in its conceptualization of disease.